最終更新日:2022/12/24

HER-2-based ADC targeting have been investigated for clinical application in breast cancer treatment [11, 12 ] using trastuzumab emtasime (trastuzumab-DM1; T-DM1), in which trastuzumab is conjugated through a stable thioether bond to the maytansanoid derivative emtasine.

編集履歴(0)

Sentence quizzes to help you learn to read

編集履歴(0)

ログイン / 新規登録

 

アプリをダウンロード!
DiQt

DiQt(ディクト)

無料

★★★★★★★★★★